Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Exchange Rate Effect (2021 - 2025)

Medicinova (MNOV) has disclosed Exchange Rate Effect for 6 consecutive years, with $22575.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect changed N/A to $22575.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3465.0, a N/A change, with the full-year FY2025 number at $15681.0, up 296.29% from a year prior.
  • Exchange Rate Effect was $22575.0 for Q4 2025 at Medicinova, up from -$4611.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $22575.0 in Q4 2025 to a low of -$25345.0 in Q3 2024.
  • A 5-year average of $3399.1 and a median of $3828.0 in 2023 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 234.58% in 2024; the steepest drop was 570.83% in 2024.
  • Medicinova's Exchange Rate Effect stood at $5837.0 in 2021, then tumbled by 225.08% to -$7301.0 in 2022, then dropped by 21.64% to -$8881.0 in 2023, then plummeted by 185.38% to -$25345.0 in 2024, then surged by 189.07% to $22575.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Exchange Rate Effect are $22575.0 (Q4 2025), -$4611.0 (Q1 2025), and -$25345.0 (Q3 2024).